All In Biotech

Drug Trial Radar · NCT06104917

Effect of Maolactin on Gastrointestinal Tract (GIT) Health

Effect of MaolactinTM Supplement on Gastrointestinal Tract (GIT) Health in Adult Subjects: a Double-blind Randomized Placebo-controlled Study

Last checked: Nov 19, 2026Latest source record: Aug 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

91

Actual

Start

Feb 21, 2024

Primary completion

Jul 23, 2025

Study completion Jul 23, 2025

Sponsor

Lead sponsor
RDC Clinical Pty LtdIndustry
Sponsor type
Industry
Collaborators
Maolac
First posted
Oct 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled, 3 arm parallel group study of 12 weeks duration, with a 4-week run-in period as the control phase and an 8-week intervention period, to investigate the effectiveness of the treatment on upper GI disturbance.

Conditions

  • Gastrointestinal Dysfunction

Interventions

  • High Dose MaolactinDrug

    Once daily dose of 2 capsules (2 capsules containing 250mg active proteins per capsule; equivalent to 500mg active proteins per day)

  • Low Dose MaolactinDrug

    Once daily dose of 2 capsules (1 capsule containing 250mg active proteins per capsule and 1 capsule containing maltodextrin only; equivalent to 250mg active proteins per day)

  • MaltodextrinDrug

    Once daily dose of 2 capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in upper gastrointestinal symptomsTime frame: Day -28, Day 0, Day 14, Day 28, Day 56

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • RDC Clinical Pty Ltd

    Brisbane, Queensland, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.